secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOGEN INC. (BIIB)
CIK:        0000875045
Form:       8-K
Filed at:   2026-02-11T23:59:59+00:00
Accession:  0001193125-26-046803
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Biogen Chair Caroline Dorsa to step down; Dr. Maria C. Freire elected as new Chair
--------------------------------------------------------------------------------

- Chair Caroline Dorsa will not stand for re-election at the 2026 Annual Meeting; decision unrelated to any disagreement.
- Board elected Dr. Maria C. Freire to serve as Chair, effective after the Annual Meeting.
- Dr. Freire's appointment marks an orderly transition of Board leadership.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/875045/000119312526046803/0001193125-26-046803-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/875045/000119312526046803/d937279d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-046803

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer